查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1871995

皮肤微生物组调节剂：全球市场份额和排名、总收入和需求预测（2025-2031年）

Skin Microbiome Modulator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 91 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球皮肤微生物组调节剂市场预计在 2024 年达到 7.92 亿美元，预计到 2031 年将达到 19.61 亿美元，在预测期（2025-2031 年）内以 13.8% 的复合年增长率增长。

皮肤微生态调节剂是一类功能性物质或产品，它们透过调节皮肤表面微生物群落的组成、结构和代谢活性，维持或恢復皮肤微生态的平衡，从而改善或促进皮肤健康。这类物质包括益生菌、益生元、后生元、微生物代谢物和天然植物萃取物。它们能够促进有益菌的生长，抑制致病微生物，增强皮肤屏障功能，并调节免疫反应。它们适用于多种护肤用途，包括抗炎、抗过敏、抗痤疮和抗衰老。随着人们对皮肤微生态与皮肤疾病之间关係的认识不断加深，皮肤微生态调节剂已成为现代皮肤病学、化妆品研发和个人化护肤的重要研究方向，并广泛应用于医学护肤和功能性化妆品领域。

皮肤微生物群调节剂正逐渐成为护肤技术领域的新焦点。它们透过调节皮肤表面的微生物群落，维持并恢復皮肤微生态的平衡，从而改善皮肤屏障功能和整体健康。目前，这些调节剂主要分为三类：益生菌（如嗜酸乳桿菌和表皮葡萄球菌等活性微生物）直接影响皮肤微生态；益生元（如果寡糖和菊糖）为有益菌提供营养，促进其增殖和定植；此外，药用级调节剂，包括抗菌肽和靶向微生物生态学的分子，主要用于特异性抑制致病菌和调节免疫反应。这些调节剂广泛用于护肤品（消炎、祛痘、抗过敏、保湿等）和护髮产品（舒缓头皮、控制皮脂、促进头髮生长等），并逐渐扩展到其他高潜力领域，如医疗辅助护肤、婴儿护理、男性护理和术后修復。

全球领先的皮肤微生物群调节剂生产商包括欧莱雅集团、联合利华和雅诗兰黛集团。这三大公司占据了约27%的全球市场。按地区划分，美洲是最大的市场，市占率约33%，其次是亚太地区（32%）和欧洲（26%）。

随着微生物组学、合成生物学和皮肤病学的融合日益深入，皮肤微生物组调节技术将朝着更精准、个人化和智慧化的方向发展。例如，透过人工智慧分析个体皮肤微生物状态来客製化个人化的调节方案，以及开发可控释放的活菌递送系统，都将成为业界的突破性进展。同时，随着消费者对高效护肤以及天然安全产品的需求日益增长，调节技术也必须兼顾科学检验和环境永续性。

在这一发展浪潮中，製造商应积极转变角色，从单纯的原材料供应商转型为皮肤微生物组解决方案的提供者。一方面，应加强皮肤微生物机制、菌丛交互作用及稳压器作用机制的基础研究，以推进临床疗效检验及标准化评估系统的建立。另一方面，应探索多样化的产品形态（冻干粉、微胶囊、即时製剂等），以提高产品的易用性和成分稳定性。此外，製造商还应关注监管趋势和行业标准配方，加强与品牌所有者和研究机构的合作，完善知识产权和专利联盟，构建以微生态护肤为核心的新竞争优势，推动皮肤微生物组调节剂从技术概念向大规模产品市场的真正转型。

本报告旨在按地区/国家、类型和应用对全球皮肤微生物组调节剂市场进行全面分析，重点关注总收入、市场份额和主要企业的排名。

本报告基于2020年至2031年的历史数据和预测数据（以2024年为基准年），提供了皮肤微生物组调节剂的市场规模、估算和预测（以销售收入计）。定量和定性分析将帮助读者制定业务和成长策略，评估竞争格局，分析自身在当前市场中的地位，并就皮肤微生物组调节剂做出明智的商业决策。

市场区隔

公司

  • L'Oreal
  • Unilever
  • The Estee Lauder Companies
  • Johnson & Johnson
  • Revlon
  • Evelo Biosciences
  • AOBiome
  • Azitra
  • GALLINEE
  • Glowbiotics

按类型分類的细分市场

  • 益生菌
  • 益生元
  • 製药

应用领域

  • 护肤
  • 护髮
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Skin Microbiome Modulator was estimated to be worth US$ 792 million in 2024 and is forecast to a readjusted size of US$ 1961 million by 2031 with a CAGR of 13.8% during the forecast period 2025-2031.

Skin microbiome regulators refer to a class of functional substances or products that maintain or restore the balance of skin microecology by regulating the composition, structure and metabolic activity of the microbial community on the skin surface, thereby improving or enhancing the health of the skin. Such regulators include probiotics, prebiotics, postbiotics, microecological metabolites, natural plant extracts, etc., which can promote the growth of beneficial bacteria, inhibit pathogenic microorganisms, enhance skin barrier function and regulate immune response. They are suitable for multiple skin care fields such as anti-inflammatory, anti-allergic, anti-acne, and anti-aging. With the in-depth understanding of the relationship between skin microecology and skin diseases, skin microbiome regulators have become an important direction of modern dermatology, cosmetic development and personalized skin care, and have been widely used in medical skin care and functional cosmetics.

Skin microbiome regulators are gradually becoming an emerging focus in the field of skin care technology. They help maintain or restore the balance of the microecology by regulating the microbial community on the surface of the skin, thereby improving the skin barrier function and overall health. At present, such regulators can be mainly divided into three categories: probiotics (such as active microorganisms such as Lactobacillus and Staphylococcus epidermidis), which can directly act on the skin microecology; prebiotics (such as oligofructose, inulin, etc.), which promote the reproduction and colonization of beneficial bacteria by providing nutrition for them; and pharmaceutical regulators, including antimicrobial peptides, microecological targeting molecules, etc., are more used to specifically inhibit pathogenic bacteria or regulate immune responses. These regulators have been widely used in skin care products (such as anti-inflammatory, anti-acne, anti-allergic, and moisturizing facial skin care products), hair care products (such as scalp soothing, oil control, and anti-hair loss products), and gradually expanded to "other" high-potential scenarios such as medical-assisted skin care, infant care, men's care, and postoperative repair.

The core manufacturers of global skin microbiome regulators include L'Oreal S.A., Unilever and The Estee Lauder Companies, etc. The top three manufacturers account for about 27% of the global market share. The Americas is the world's largest market, accounting for about 33% of the market share, followed by Asia Pacific and Europe, accounting for 32% and 26% respectively.

With the deepening integration of microbiome, synthetic biology and skin science, skin microbiome regulators will develop in a more precise, personalized and intelligent direction in the future. For example, customizing personalized regulation plans through AI analysis of individual skin microecological status, or developing a controlled release live bacteria delivery system, will become a breakthrough in the industry. At the same time, with the increase in consumers' dual demands for "effective skin care" and "natural safety", regulator products must also take into account scientific verification and green sustainability.

In this wave of development, manufacturers should actively change their roles from a simple raw material supplier to a microecological solution provider. On the one hand, we should increase basic research on the skin microecological mechanism, flora interaction, and regulator efficacy mechanism, and promote clinical efficacy verification and the construction of a standardized evaluation system; on the other hand, we should explore diversified product forms (such as freeze-dried powder, encapsulated microcapsules, and instant activation preparations) to improve ease of use and ingredient stability. In addition, manufacturers should also pay attention to regulatory trends and industry standard formulation, strengthen cooperation with brand owners and scientific research institutions, lay out intellectual property and patent pools, build new competitive advantages with microecological skin care as the core, and promote the true transformation of skin microbiome regulators from technical concepts to large-scale product markets.

This report aims to provide a comprehensive presentation of the global market for Skin Microbiome Modulator, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Skin Microbiome Modulator by region & country, by Type, and by Application.

The Skin Microbiome Modulator market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Skin Microbiome Modulator.

Market Segmentation

By Company

  • L'Oreal
  • Unilever
  • The Estee Lauder Companies
  • Johnson & Johnson
  • Revlon
  • Evelo Biosciences
  • AOBiome
  • Azitra
  • GALLINEE
  • Glowbiotics

Segment by Type

  • Probiotics
  • Prebiotics
  • Drugs

Segment by Application

  • Skin Care
  • Hair Care
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Skin Microbiome Modulator company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Skin Microbiome Modulator in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Skin Microbiome Modulator in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Skin Microbiome Modulator Product Introduction
  • 1.2 Global Skin Microbiome Modulator Market Size Forecast (2020-2031)
  • 1.3 Skin Microbiome Modulator Market Trends & Drivers
    • 1.3.1 Skin Microbiome Modulator Industry Trends
    • 1.3.2 Skin Microbiome Modulator Market Drivers & Opportunity
    • 1.3.3 Skin Microbiome Modulator Market Challenges
    • 1.3.4 Skin Microbiome Modulator Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Skin Microbiome Modulator Players Revenue Ranking (2024)
  • 2.2 Global Skin Microbiome Modulator Revenue by Company (2020-2025)
  • 2.3 Key Companies Skin Microbiome Modulator Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Skin Microbiome Modulator Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Skin Microbiome Modulator
  • 2.6 Skin Microbiome Modulator Market Competitive Analysis
    • 2.6.1 Skin Microbiome Modulator Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Skin Microbiome Modulator Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Microbiome Modulator as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Probiotics
    • 3.1.2 Prebiotics
    • 3.1.3 Drugs
  • 3.2 Global Skin Microbiome Modulator Sales Value by Type
    • 3.2.1 Global Skin Microbiome Modulator Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Skin Microbiome Modulator Sales Value, by Type (2020-2031)
    • 3.2.3 Global Skin Microbiome Modulator Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Skin Care
    • 4.1.2 Hair Care
    • 4.1.3 Others
  • 4.2 Global Skin Microbiome Modulator Sales Value by Application
    • 4.2.1 Global Skin Microbiome Modulator Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Skin Microbiome Modulator Sales Value, by Application (2020-2031)
    • 4.2.3 Global Skin Microbiome Modulator Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Skin Microbiome Modulator Sales Value by Region
    • 5.1.1 Global Skin Microbiome Modulator Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Skin Microbiome Modulator Sales Value by Region (2020-2025)
    • 5.1.3 Global Skin Microbiome Modulator Sales Value by Region (2026-2031)
    • 5.1.4 Global Skin Microbiome Modulator Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Skin Microbiome Modulator Sales Value, 2020-2031
    • 5.2.2 North America Skin Microbiome Modulator Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Skin Microbiome Modulator Sales Value, 2020-2031
    • 5.3.2 Europe Skin Microbiome Modulator Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Skin Microbiome Modulator Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Skin Microbiome Modulator Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Skin Microbiome Modulator Sales Value, 2020-2031
    • 5.5.2 South America Skin Microbiome Modulator Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Skin Microbiome Modulator Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Skin Microbiome Modulator Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Skin Microbiome Modulator Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Skin Microbiome Modulator Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Skin Microbiome Modulator Sales Value, 2020-2031
    • 6.3.2 United States Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Skin Microbiome Modulator Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Skin Microbiome Modulator Sales Value, 2020-2031
    • 6.4.2 Europe Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Skin Microbiome Modulator Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Skin Microbiome Modulator Sales Value, 2020-2031
    • 6.5.2 China Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Skin Microbiome Modulator Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Skin Microbiome Modulator Sales Value, 2020-2031
    • 6.6.2 Japan Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Skin Microbiome Modulator Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Skin Microbiome Modulator Sales Value, 2020-2031
    • 6.7.2 South Korea Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Skin Microbiome Modulator Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Skin Microbiome Modulator Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Skin Microbiome Modulator Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Skin Microbiome Modulator Sales Value, 2020-2031
    • 6.9.2 India Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Skin Microbiome Modulator Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 L'Oreal
    • 7.1.1 L'Oreal Profile
    • 7.1.2 L'Oreal Main Business
    • 7.1.3 L'Oreal Skin Microbiome Modulator Products, Services and Solutions
    • 7.1.4 L'Oreal Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
    • 7.1.5 L'Oreal Recent Developments
  • 7.2 Unilever
    • 7.2.1 Unilever Profile
    • 7.2.2 Unilever Main Business
    • 7.2.3 Unilever Skin Microbiome Modulator Products, Services and Solutions
    • 7.2.4 Unilever Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Unilever Recent Developments
  • 7.3 The Estee Lauder Companies
    • 7.3.1 The Estee Lauder Companies Profile
    • 7.3.2 The Estee Lauder Companies Main Business
    • 7.3.3 The Estee Lauder Companies Skin Microbiome Modulator Products, Services and Solutions
    • 7.3.4 The Estee Lauder Companies Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
    • 7.3.5 The Estee Lauder Companies Recent Developments
  • 7.4 Johnson & Johnson
    • 7.4.1 Johnson & Johnson Profile
    • 7.4.2 Johnson & Johnson Main Business
    • 7.4.3 Johnson & Johnson Skin Microbiome Modulator Products, Services and Solutions
    • 7.4.4 Johnson & Johnson Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Johnson & Johnson Recent Developments
  • 7.5 Revlon
    • 7.5.1 Revlon Profile
    • 7.5.2 Revlon Main Business
    • 7.5.3 Revlon Skin Microbiome Modulator Products, Services and Solutions
    • 7.5.4 Revlon Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Revlon Recent Developments
  • 7.6 Evelo Biosciences
    • 7.6.1 Evelo Biosciences Profile
    • 7.6.2 Evelo Biosciences Main Business
    • 7.6.3 Evelo Biosciences Skin Microbiome Modulator Products, Services and Solutions
    • 7.6.4 Evelo Biosciences Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Evelo Biosciences Recent Developments
  • 7.7 AOBiome
    • 7.7.1 AOBiome Profile
    • 7.7.2 AOBiome Main Business
    • 7.7.3 AOBiome Skin Microbiome Modulator Products, Services and Solutions
    • 7.7.4 AOBiome Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
    • 7.7.5 AOBiome Recent Developments
  • 7.8 Azitra
    • 7.8.1 Azitra Profile
    • 7.8.2 Azitra Main Business
    • 7.8.3 Azitra Skin Microbiome Modulator Products, Services and Solutions
    • 7.8.4 Azitra Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Azitra Recent Developments
  • 7.9 GALLINEE
    • 7.9.1 GALLINEE Profile
    • 7.9.2 GALLINEE Main Business
    • 7.9.3 GALLINEE Skin Microbiome Modulator Products, Services and Solutions
    • 7.9.4 GALLINEE Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
    • 7.9.5 GALLINEE Recent Developments
  • 7.10 Glowbiotics
    • 7.10.1 Glowbiotics Profile
    • 7.10.2 Glowbiotics Main Business
    • 7.10.3 Glowbiotics Skin Microbiome Modulator Products, Services and Solutions
    • 7.10.4 Glowbiotics Skin Microbiome Modulator Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Glowbiotics Recent Developments

8 Industry Chain Analysis

  • 8.1 Skin Microbiome Modulator Industrial Chain
  • 8.2 Skin Microbiome Modulator Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Skin Microbiome Modulator Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Skin Microbiome Modulator Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Skin Microbiome Modulator Market Trends
  • Table 2. Skin Microbiome Modulator Market Drivers & Opportunity
  • Table 3. Skin Microbiome Modulator Market Challenges
  • Table 4. Skin Microbiome Modulator Market Restraints
  • Table 5. Global Skin Microbiome Modulator Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Skin Microbiome Modulator Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Skin Microbiome Modulator Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Skin Microbiome Modulator Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Skin Microbiome Modulator
  • Table 10. Global Skin Microbiome Modulator Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Microbiome Modulator as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Skin Microbiome Modulator Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Skin Microbiome Modulator Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Skin Microbiome Modulator Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Skin Microbiome Modulator Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Skin Microbiome Modulator Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Skin Microbiome Modulator Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Skin Microbiome Modulator Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Skin Microbiome Modulator Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Skin Microbiome Modulator Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Skin Microbiome Modulator Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Skin Microbiome Modulator Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Skin Microbiome Modulator Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Skin Microbiome Modulator Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Skin Microbiome Modulator Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Skin Microbiome Modulator Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Skin Microbiome Modulator Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Skin Microbiome Modulator Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Skin Microbiome Modulator Sales Value, (2026-2031) & (US$ Million)
  • Table 31. L'Oreal Basic Information List
  • Table 32. L'Oreal Description and Business Overview
  • Table 33. L'Oreal Skin Microbiome Modulator Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Skin Microbiome Modulator Business of L'Oreal (2020-2025)
  • Table 35. L'Oreal Recent Developments
  • Table 36. Unilever Basic Information List
  • Table 37. Unilever Description and Business Overview
  • Table 38. Unilever Skin Microbiome Modulator Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Skin Microbiome Modulator Business of Unilever (2020-2025)
  • Table 40. Unilever Recent Developments
  • Table 41. The Estee Lauder Companies Basic Information List
  • Table 42. The Estee Lauder Companies Description and Business Overview
  • Table 43. The Estee Lauder Companies Skin Microbiome Modulator Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Skin Microbiome Modulator Business of The Estee Lauder Companies (2020-2025)
  • Table 45. The Estee Lauder Companies Recent Developments
  • Table 46. Johnson & Johnson Basic Information List
  • Table 47. Johnson & Johnson Description and Business Overview
  • Table 48. Johnson & Johnson Skin Microbiome Modulator Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Skin Microbiome Modulator Business of Johnson & Johnson (2020-2025)
  • Table 50. Johnson & Johnson Recent Developments
  • Table 51. Revlon Basic Information List
  • Table 52. Revlon Description and Business Overview
  • Table 53. Revlon Skin Microbiome Modulator Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Skin Microbiome Modulator Business of Revlon (2020-2025)
  • Table 55. Revlon Recent Developments
  • Table 56. Evelo Biosciences Basic Information List
  • Table 57. Evelo Biosciences Description and Business Overview
  • Table 58. Evelo Biosciences Skin Microbiome Modulator Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Skin Microbiome Modulator Business of Evelo Biosciences (2020-2025)
  • Table 60. Evelo Biosciences Recent Developments
  • Table 61. AOBiome Basic Information List
  • Table 62. AOBiome Description and Business Overview
  • Table 63. AOBiome Skin Microbiome Modulator Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Skin Microbiome Modulator Business of AOBiome (2020-2025)
  • Table 65. AOBiome Recent Developments
  • Table 66. Azitra Basic Information List
  • Table 67. Azitra Description and Business Overview
  • Table 68. Azitra Skin Microbiome Modulator Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Skin Microbiome Modulator Business of Azitra (2020-2025)
  • Table 70. Azitra Recent Developments
  • Table 71. GALLINEE Basic Information List
  • Table 72. GALLINEE Description and Business Overview
  • Table 73. GALLINEE Skin Microbiome Modulator Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Skin Microbiome Modulator Business of GALLINEE (2020-2025)
  • Table 75. GALLINEE Recent Developments
  • Table 76. Glowbiotics Basic Information List
  • Table 77. Glowbiotics Description and Business Overview
  • Table 78. Glowbiotics Skin Microbiome Modulator Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Skin Microbiome Modulator Business of Glowbiotics (2020-2025)
  • Table 80. Glowbiotics Recent Developments
  • Table 81. Key Raw Materials Lists
  • Table 82. Raw Materials Key Suppliers Lists
  • Table 83. Skin Microbiome Modulator Downstream Customers
  • Table 84. Skin Microbiome Modulator Distributors List
  • Table 85. Research Programs/Design for This Report
  • Table 86. Key Data Information from Secondary Sources
  • Table 87. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Skin Microbiome Modulator Product Picture
  • Figure 2. Global Skin Microbiome Modulator Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Skin Microbiome Modulator Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Skin Microbiome Modulator Report Years Considered
  • Figure 5. Global Skin Microbiome Modulator Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Skin Microbiome Modulator Revenue in 2024
  • Figure 7. Skin Microbiome Modulator Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Probiotics Picture
  • Figure 9. Prebiotics Picture
  • Figure 10. Drugs Picture
  • Figure 11. Global Skin Microbiome Modulator Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 12. Global Skin Microbiome Modulator Sales Value Market Share by Type, 2024 & 2031
  • Figure 13. Product Picture of Skin Care
  • Figure 14. Product Picture of Hair Care
  • Figure 15. Product Picture of Others
  • Figure 16. Global Skin Microbiome Modulator Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 17. Global Skin Microbiome Modulator Sales Value Market Share by Application, 2024 & 2031
  • Figure 18. North America Skin Microbiome Modulator Sales Value (2020-2031) & (US$ Million)
  • Figure 19. North America Skin Microbiome Modulator Sales Value by Country (%), 2024 VS 2031
  • Figure 20. Europe Skin Microbiome Modulator Sales Value, (2020-2031) & (US$ Million)
  • Figure 21. Europe Skin Microbiome Modulator Sales Value by Country (%), 2024 VS 2031
  • Figure 22. Asia Pacific Skin Microbiome Modulator Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. Asia Pacific Skin Microbiome Modulator Sales Value by Region (%), 2024 VS 2031
  • Figure 24. South America Skin Microbiome Modulator Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. South America Skin Microbiome Modulator Sales Value by Country (%), 2024 VS 2031
  • Figure 26. Middle East & Africa Skin Microbiome Modulator Sales Value, (2020-2031) & (US$ Million)
  • Figure 27. Middle East & Africa Skin Microbiome Modulator Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Key Countries/Regions Skin Microbiome Modulator Sales Value (%), (2020-2031)
  • Figure 29. United States Skin Microbiome Modulator Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. United States Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
  • Figure 31. United States Skin Microbiome Modulator Sales Value by Application (%), 2024 VS 2031
  • Figure 32. Europe Skin Microbiome Modulator Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. Europe Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
  • Figure 34. Europe Skin Microbiome Modulator Sales Value by Application (%), 2024 VS 2031
  • Figure 35. China Skin Microbiome Modulator Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. China Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
  • Figure 37. China Skin Microbiome Modulator Sales Value by Application (%), 2024 VS 2031
  • Figure 38. Japan Skin Microbiome Modulator Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. Japan Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
  • Figure 40. Japan Skin Microbiome Modulator Sales Value by Application (%), 2024 VS 2031
  • Figure 41. South Korea Skin Microbiome Modulator Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. South Korea Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
  • Figure 43. South Korea Skin Microbiome Modulator Sales Value by Application (%), 2024 VS 2031
  • Figure 44. Southeast Asia Skin Microbiome Modulator Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. Southeast Asia Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
  • Figure 46. Southeast Asia Skin Microbiome Modulator Sales Value by Application (%), 2024 VS 2031
  • Figure 47. India Skin Microbiome Modulator Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. India Skin Microbiome Modulator Sales Value by Type (%), 2024 VS 2031
  • Figure 49. India Skin Microbiome Modulator Sales Value by Application (%), 2024 VS 2031
  • Figure 50. Skin Microbiome Modulator Industrial Chain
  • Figure 51. Skin Microbiome Modulator Manufacturing Cost Structure
  • Figure 52. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 53. Bottom-up and Top-down Approaches for This Report
  • Figure 54. Data Triangulation
  • Figure 55. Key Executives Interviewed